SG Americas Securities’s Neurocrine Biosciences NBIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $608K | Sell |
4,834
-170,779
| -97% | -$21.5M | ﹤0.01% | 1379 |
|
2025
Q1 | $19.4M | Buy |
175,613
+174,551
| +16,436% | +$19.3M | 0.06% | 184 |
|
2024
Q4 | $145K | Sell |
1,062
-7,022
| -87% | -$959K | ﹤0.01% | 2170 |
|
2024
Q3 | $931K | Sell |
8,084
-34,394
| -81% | -$3.96M | ﹤0.01% | 989 |
|
2024
Q2 | $5.85M | Buy |
+42,478
| New | +$5.85M | 0.03% | 444 |
|
2024
Q1 | – | Sell |
-7,180
| Closed | -$946K | – | 2849 |
|
2023
Q4 | $946K | Sell |
7,180
-17,273
| -71% | -$2.28M | 0.01% | 941 |
|
2023
Q3 | $2.75M | Buy |
+24,453
| New | +$2.75M | 0.03% | 507 |
|
2023
Q2 | – | Sell |
-30,030
| Closed | -$3.04M | – | 2507 |
|
2023
Q1 | $3.04M | Buy |
30,030
+22,676
| +308% | +$2.3M | 0.04% | 411 |
|
2022
Q4 | $878K | Buy |
+7,354
| New | +$878K | 0.01% | 936 |
|
2022
Q3 | – | Sell |
-20,700
| Closed | -$2.02M | – | 3007 |
|
2022
Q2 | $2.02M | Sell |
20,700
-22,553
| -52% | -$2.2M | 0.02% | 637 |
|
2022
Q1 | $4.06M | Sell |
43,253
-76
| -0.2% | -$7.13K | 0.03% | 439 |
|
2021
Q4 | $3.69M | Buy |
43,329
+5,131
| +13% | +$437K | 0.02% | 576 |
|
2021
Q3 | $3.66M | Buy |
38,198
+3,223
| +9% | +$309K | 0.02% | 668 |
|
2021
Q2 | $3.4M | Sell |
34,975
-19,636
| -36% | -$1.91M | 0.02% | 721 |
|
2021
Q1 | $5.31M | Buy |
54,611
+48,039
| +731% | +$4.67M | 0.03% | 429 |
|
2020
Q4 | $630K | Sell |
6,572
-9,356
| -59% | -$897K | ﹤0.01% | 1591 |
|
2020
Q3 | $1.53M | Buy |
15,928
+4,576
| +40% | +$440K | 0.01% | 758 |
|
2020
Q2 | $1.39M | Sell |
11,352
-6,814
| -38% | -$831K | 0.01% | 908 |
|
2020
Q1 | $1.57M | Buy |
18,166
+16,821
| +1,251% | +$1.46M | 0.01% | 727 |
|
2019
Q4 | $145K | Sell |
1,345
-2,234
| -62% | -$241K | ﹤0.01% | 2339 |
|
2019
Q3 | $323K | Sell |
3,579
-1,413
| -28% | -$128K | ﹤0.01% | 1824 |
|
2019
Q2 | $421K | Buy |
4,992
+2,886
| +137% | +$243K | ﹤0.01% | 1730 |
|
2019
Q1 | $186K | Buy |
2,106
+135
| +7% | +$11.9K | ﹤0.01% | 2295 |
|
2018
Q4 | $141K | Buy |
1,971
+157
| +9% | +$11.2K | ﹤0.01% | 2166 |
|
2018
Q3 | $223K | Sell |
1,814
-27,426
| -94% | -$3.37M | ﹤0.01% | 2192 |
|
2018
Q2 | $2.87M | Buy |
29,240
+27,904
| +2,089% | +$2.74M | 0.03% | 635 |
|
2018
Q1 | $111K | Sell |
1,336
-3,092
| -70% | -$257K | ﹤0.01% | 2451 |
|
2017
Q4 | $344K | Buy |
+4,428
| New | +$344K | ﹤0.01% | 1764 |
|
2017
Q3 | – | Sell |
-2,326
| Closed | -$107K | – | 3068 |
|
2017
Q2 | $107K | Sell |
2,326
-36,446
| -94% | -$1.68M | ﹤0.01% | 2499 |
|
2017
Q1 | $1.68M | Sell |
38,772
-20,897
| -35% | -$905K | 0.01% | 932 |
|
2016
Q4 | $2.31M | Buy |
59,669
+56,428
| +1,741% | +$2.18M | 0.02% | 780 |
|
2016
Q3 | $164K | Buy |
+3,241
| New | +$164K | ﹤0.01% | 2352 |
|
2016
Q2 | – | Sell |
-7,091
| Closed | -$280K | – | 2372 |
|
2016
Q1 | $280K | Buy |
+7,091
| New | +$280K | ﹤0.01% | 1789 |
|
2015
Q4 | – | Sell |
-16,353
| Closed | -$651K | – | 2363 |
|
2015
Q3 | $651K | Buy |
16,353
+12,202
| +294% | +$486K | ﹤0.01% | 984 |
|
2015
Q2 | $198K | Sell |
4,151
-10,072
| -71% | -$480K | ﹤0.01% | 1712 |
|
2015
Q1 | $565K | Sell |
14,223
-1,510
| -10% | -$60K | ﹤0.01% | 1252 |
|
2014
Q4 | $351K | Buy |
+15,733
| New | +$351K | ﹤0.01% | 1707 |
|
2013
Q4 | – | Sell |
-13,310
| Closed | -$151K | – | 2393 |
|
2013
Q3 | $151K | Buy |
13,310
+4,508
| +51% | +$51.1K | ﹤0.01% | 2100 |
|
2013
Q2 | $118K | Buy |
+8,802
| New | +$118K | ﹤0.01% | 1687 |
|